Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hauptmann

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
The Journal of Pathology|November 11, 2008
Phosphorylation of the oestrogen receptor alpha at serine 305 and prediction of tamoxifen resistance in breast cancerC Holm, M Kok, R Michalides, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 17, 2015
Cytoreduction and hyperthermic intraperitoneal chemotherapy: The learning curve reassessedA M Kuijpers, M Hauptmann, A G Aalbers, et al.
The Journal of Pathology|August 23, 2008
Refinement of breast cancer classification by molecular characterization of histological special typesB Weigelt, H M Horlings, B Kreike, et al.
Breast Cancer Research and Treatment|June 6, 2013
CYP2C19 2 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatmentK Beelen, M Opdam, T M Severson, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2014
Increased breast cancer risk in in vitro fertilisation treated women with a multiple pregnancy: a new hypothesis based on historical in vitro fertilisation treatment dataI M Krul, E Groeneveld, M Spaan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 8, 2010
An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patientsM A Vollebergh, E H Lips, P M Nederlof, et al.
Journal of Internal Medicine|May 29, 2018
Perspectives for personalized therapy for patients with multidrug-resistant tuberculosisC Lange, W A Alghamdi, M H Al-Shaer, et al.
ESMO Open|August 15, 2025
Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292)M Hamann, M Christgen, O Gluz, et al.
Human Reproduction (Oxford, England)|July 9, 2018
Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserveM H van den Berg, A Overbeek, C B Lambalk, et al.
British Journal of Cancer|October 29, 2014
Increased stomach cancer risk following radiotherapy for testicular cancerM Hauptmann, S D Fossa, M Stovall, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
The Journal of Pathology|November 11, 2008
Phosphorylation of the oestrogen receptor alpha at serine 305 and prediction of tamoxifen resistance in breast cancerC Holm, M Kok, R Michalides, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 17, 2015
Cytoreduction and hyperthermic intraperitoneal chemotherapy: The learning curve reassessedA M Kuijpers, M Hauptmann, A G Aalbers, et al.
The Journal of Pathology|August 23, 2008
Refinement of breast cancer classification by molecular characterization of histological special typesB Weigelt, H M Horlings, B Kreike, et al.
Breast Cancer Research and Treatment|June 6, 2013
CYP2C19 2 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatmentK Beelen, M Opdam, T M Severson, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2014
Increased breast cancer risk in in vitro fertilisation treated women with a multiple pregnancy: a new hypothesis based on historical in vitro fertilisation treatment dataI M Krul, E Groeneveld, M Spaan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 8, 2010
An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patientsM A Vollebergh, E H Lips, P M Nederlof, et al.
Journal of Internal Medicine|May 29, 2018
Perspectives for personalized therapy for patients with multidrug-resistant tuberculosisC Lange, W A Alghamdi, M H Al-Shaer, et al.
ESMO Open|August 15, 2025
Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292)M Hamann, M Christgen, O Gluz, et al.
Human Reproduction (Oxford, England)|July 9, 2018
Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserveM H van den Berg, A Overbeek, C B Lambalk, et al.
British Journal of Cancer|October 29, 2014
Increased stomach cancer risk following radiotherapy for testicular cancerM Hauptmann, S D Fossa, M Stovall, et al.
Pageof 10